9ZF-27256-26629 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-22
Dose 1 — Moderna
2021-05-20
Dose 2 — Moderna
2021-12-29
Dose 3 — Moderna
2021-12-30
Registered in v-safe
2021-12-30
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-12-31
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Underarm lymph node swelling

MedDRA releases: 2024-11 · check-in free text available
2022-01-01
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Good · Site: Swelling

Free text: Underarm lymph node swelling

MedDRA releases: 2024-11 · check-in free text available
2022-01-02
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain, Swelling · Muscle or body aches

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-22	Moderna	No
2	2021-05-20	Moderna	No
3	2021-12-29	Moderna	No

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-31

Systemic reaction (other): Underarm lymph node swelling

2022-01-01

Systemic reaction (other): Underarm lymph node swelling

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Lymphadenopathy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release